alexa Robust and powerful tests for rare variants using Fisher's method to combine evidence of association from two or more complementary tests.
Genetics & Molecular Biology

Genetics & Molecular Biology

Human Genetics & Embryology

Author(s): Derkach A, Lawless JF, Sun L

Abstract Share this page

Abstract Many association tests have been proposed for rare variants, but the choice of a powerful test is uncertain when there is limited information on the underlying genetic model. Proposed methods use either linear statistics, which are powerful when most variants are causal and have the same direction of effect, or quadratic statistics, which are more powerful in other scenarios. To achieve robustness, it is natural to combine the evidence of association from two or more complementary tests. To this end, we consider the minimum-p and Fisher's methods of combining P-values from linear and quadratic statistics. Extensive simulation studies show that both methods are robust across models with varying proportions of causal, deleterious, and protective rare variants, allele frequencies, and effect sizes. When the majority (>75\%) of the causal effects are in the same direction (deleterious or protective), Fisher's method consistently outperforms the minimum-p and the individual linear and quadratic tests, as well as the optimal sequence kernel association test, SKAT-O. When the individual test has moderate power, Fisher's test has improved power for 90\% of the ~5000 models considered, with >20\% relative efficiency gain for 40\% of the models. The maximum absolute power loss is 8\% for the remaining 10\% of the models. An application to the GAW17 quantitative trait Q2 data based on sequence data of the 1000 Genomes Project shows that, compared with linear and quadratic tests, Fisher's test has comparable power for all 13 functional genes and provides the best power for more than half of them. © 2012 Wiley Periodicals, Inc. This article was published in Genet Epidemiol and referenced in Human Genetics & Embryology

Relevant Expert PPTs

Relevant Speaker PPTs

  • Yosef Yarden
    Classically, the 3’untranslated region (3’UTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3’UTR alone, without all other elements in mRNA such as 5’UTR and coding region. The importance of independent 3’UTR RNA (referred as I3’UTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3’UTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3’UTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3’UTR were important for its tumor suppression activity. Then, the C/EBP 3’UTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3’UTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3’UTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990’s to 2000’s, world scientists found several 3’UTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3’UTR regions, although the existence of their transcribed products as independent 3’UTR RNAs is still to be confirmed. Our studies indicate that the independent 3’UTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
    PPT Version | PDF Version
  • Yongming Sang
    Genome-Wide Transcriptomes Integrate Animal Intra- and Inter-Organism Processes and Evoke the Ecoimmunological Concept in Animal Health
    PPT Version | PDF Version
  • Sang Ming WANG
    Genome-scale mapping promoter variation through exome sequencing
    PPT Version | PDF Version
  • Dele Ogunremi
    Strategy for developing a molecular sub typing tool for a food borne bacterial pathogen using a whole genome analysis approach: the case of Salmonella Enteritidis
    PPT Version | PDF Version
  • Tamar Geiger
    Genome-Scale Proteomic Profiling of Breast Cancer Progression
    PPT Version | PDF Version
  • Hehuang Xie
    Decoding epigenome with integrative omics data analysis
    PPT Version | PDF Version
  • Steven M Carr
    Novel quantitative analyses of phylogeographic structure and connectivity among marine populations as inferred from whole-genome mtDNA sequences
    PPT Version | PDF Version
  • Effie Liakopoulou
    Whole genome methodology for in silico quantification of intra tumor heterogeneity: Model for clinical applications in the treatment of patients with hematological malignancies
    PPT Version | PDF Version
  • Chuanling Zhang
    Genetic Code Expansion in Natural Propagation for Site-Specific Engineering and Tracking of Single Adeno-Associated Viruses
    PPT Version | PDF Version

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords